BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther 2021;6:307. [PMID: 34456337 DOI: 10.1038/s41392-021-00701-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Su J, Zhao J, Chen J, Cui X, Sun M, Zhang X. Curcumin inhibits invasion and metastasis of human hepatoma cells through Bclaf1-mediated Wnt/β-catenin signalling. Food and Agricultural Immunology 2022;33:664-76. [DOI: 10.1080/09540105.2022.2113864] [Reference Citation Analysis]
2 Liang J, Sun L, Li Y, Liu W, Li D, Chen P, Wang X, Hui J, Zhou J, Liu H, Cao T, Pang M, Guo M, Wang X, Zhao X, Lu Y. Wnt Signaling Modulator DKK4 Inhibits Colorectal Cancer Metastasis through an AKT/Wnt/β-catenin Negative Feedback Pathway. J Biol Chem 2022;:102545. [PMID: 36181792 DOI: 10.1016/j.jbc.2022.102545] [Reference Citation Analysis]
3 Ouyang X, Xu C. Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-04373-8] [Reference Citation Analysis]
4 Yu C, Rao D, Wang T, Song J, Zhang L, Huang W. Emerging roles of TRIM27 in cancer and other human diseases. Front Cell Dev Biol 2022;10:1004429. [DOI: 10.3389/fcell.2022.1004429] [Reference Citation Analysis]
5 Fu D, Hu Z, Xu X, Dai X, Liu Z. Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities. Transl Oncol 2022;26:101510. [PMID: 36122506 DOI: 10.1016/j.tranon.2022.101510] [Reference Citation Analysis]
6 Lu M, Lan X, Wu X, Fang X, Zhang Y, Luo H, Gao W, Wu D. Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes. Front Pharmacol 2022;13:1008222. [DOI: 10.3389/fphar.2022.1008222] [Reference Citation Analysis]
7 Hewitt DB, Aziz H, Brown ZJ, Pawlik TM. Role of genetic testing in hepatic, pancreatic, and biliary cancers. Surg Oncol 2022;44:101844. [PMID: 36116416 DOI: 10.1016/j.suronc.2022.101844] [Reference Citation Analysis]
8 Chen J, Wang X, Zhang J, Chang J, Han C, Xu Z, Yu H, Teekaraman Y. Effects of the Wnt/β-Catenin Signaling Pathway on Proliferation and Apoptosis of Gastric Cancer Cells. Contrast Media & Molecular Imaging 2022;2022:1-6. [DOI: 10.1155/2022/5132691] [Reference Citation Analysis]
9 Li L, Chen S, Tang Y, Wu J, He Y, Qiu L. Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of NBPF1. Front Endocrinol 2022;13:950326. [DOI: 10.3389/fendo.2022.950326] [Reference Citation Analysis]
10 Guo J, Zhao J, Fu W, Xu Q, Huang D. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms. Front Immunol 2022;13:918314. [DOI: 10.3389/fimmu.2022.918314] [Reference Citation Analysis]
11 Wu J, Zhang Y, Li X, Ren J, Chen L, Chen J, Cao Y. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a. Biochem Biophys Res Commun 2022;622:149-56. [PMID: 35863089 DOI: 10.1016/j.bbrc.2022.07.017] [Reference Citation Analysis]
12 Lo Sardo F, Canu V, Maugeri-Saccà M, Strano S, Blandino G. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers. Biochim Biophys Acta Rev Cancer 2022;1877:188756. [PMID: 35777600 DOI: 10.1016/j.bbcan.2022.188756] [Reference Citation Analysis]
13 Ma TL, Zhu P, Chen JX, Hu YH, Xie J. SIX3 function in cancer: progression and comprehensive analysis. Cancer Gene Ther 2022. [PMID: 35764712 DOI: 10.1038/s41417-022-00488-9] [Reference Citation Analysis]
14 Nascente EP, Amorim RL, Fonseca-Alves CE, de Moura VMBD. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions. Cancers (Basel) 2022;14:2727. [PMID: 35681707 DOI: 10.3390/cancers14112727] [Reference Citation Analysis]
15 Yang Q, Zhai X, Lv Y. A Bibliometric Analysis of Triptolide and the Recent Advances in Treating Non–Small Cell Lung Cancer. Front Pharmacol 2022;13:878726. [DOI: 10.3389/fphar.2022.878726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Torrigiani F, Moccia V, Brunetti B, Millanta F, Valdivia G, Peña L, Cavicchioli L, Zappulli V. Mammary Fibroadenoma in Cats: A Matter of Classification. Veterinary Sciences 2022;9:253. [DOI: 10.3390/vetsci9060253] [Reference Citation Analysis]
17 Aghanejad A, Bonab SF, Sepehri M, Haghighi FS, Tarighatnia A, Kreiter C, Nader ND, Tohidkia MR. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol 2022;207:592-610. [PMID: 35296439 DOI: 10.1016/j.ijbiomac.2022.03.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Selvaggi F, Catalano T, Cotellese R, Aceto GM. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022;14:1912. [DOI: 10.3390/cancers14081912] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Shi C, Li S, Shen C, Pan F, Deng L, Fu W, Wang J, Zhang J. Icariside II suppressed tumorigenesis by epigenetically regulating the circβ-catenin-Wnt/β-catenin axis in colorectal cancer. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105800] [Reference Citation Analysis]
20 Liu Y, Zhou WL. LINC01315 accelerates the growth and epithelial-mesenchymal transition of colorectal cancer cells via activating the Wnt/β-catenin signal. Bioengineered 2022;13:8396-406. [PMID: 35322763 DOI: 10.1080/21655979.2022.2044275] [Reference Citation Analysis]
21 Shah K, Kazi JU. Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling. Front Oncol 2022;12:858782. [DOI: 10.3389/fonc.2022.858782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Carlisi D, Lauricella M, D'Anneo A, De Blasio A, Celesia A, Pratelli G, Notaro A, Calvaruso G, Giuliano M, Emanuele S. Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties. Biomedicines 2022;10:514. [PMID: 35203723 DOI: 10.3390/biomedicines10020514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Koushyar S, Meniel VS, Phesse TJ, Pearson HB. Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer. Biomolecules 2022;12:309. [DOI: 10.3390/biom12020309] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zeng L, Yuan S, Zhou P, Gong J, Kong X, Wu M. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Bioengineered 2021;12:11795-810. [PMID: 34927541 DOI: 10.1080/21655979.2021.2008639] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Ju Q, Jiang M, Huang W, Yang Q, Luo Z, Shi H. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway. Oncol Rep 2022;47:29. [PMID: 34878149 DOI: 10.3892/or.2021.8240] [Reference Citation Analysis]